Angiogenic factors are associated with multiple sclerosis

Area of Science:

• Neuroimmunology
• Angiogenesis research
• Infectious disease links to neurodegeneration

Background:

• Angiogenesis, the formation of new blood vessels, is increasingly implicated in the pathology of multiple sclerosis (MS).
• Previous studies in animal models suggest that inhibiting angiogenesis can improve MS outcomes.
• The role of specific angiogenic factors and their correlation with Epstein-Barr virus (EBV) in human MS remains to be fully elucidated.

Purpose of the Study:

• To investigate serum levels of key angiogenic factors: vascular-endothelial growth factor (VEGF), soluble Endoglin (sEng), angiopoietin 1 (Ang-1), and angiopoietin 2 (Ang-2) in multiple sclerosis (MS) patients.
• To assess the association of these angiogenic factors with disease activity, treatment status (interferon-beta), and Epstein-Barr virus (EBV) antibody titers in MS patients.
• To evaluate serum uric acid (UA) levels and their relationship with MS and angiogenic markers.

Main Methods:

• Serum samples were collected from 50 MS patients (20 newly diagnosed, 30 on interferon-beta treatment) and 40 healthy controls.
• Vascular-endothelial growth factor (VEGF), soluble Endoglin (sEng), angiopoietin 1 (Ang-1), and angiopoietin 2 (Ang-2) were quantified using enzyme-linked immunosorbent assays (ELISA).
• Uric acid (UA) was measured via a uricase quantitative enzymatic assay, and anti-EBV EBNA-1 IgG titers were determined.

Main Results:

• MS patients exhibited significantly elevated serum levels of VEGF, Ang-1, Ang-2, and sEng compared to healthy individuals.
• Newly diagnosed MS patients showed higher VEGF levels than those on interferon-beta, with VEGF levels correlating with the Expanded Disability Status Scale (EDSS).
• Serum UA levels were lower in MS patients, while anti-EBV antibody titers were higher and correlated positively with angiogenic factors.

Conclusions:

• Angiogenesis appears to play a significant role in the pathogenesis of multiple sclerosis (MS).
• Elevated angiogenic factors and altered uric acid levels are characteristic of MS.
• Epstein-Barr virus (EBV) infection may be linked to the angiogenic process in MS, suggesting potential therapeutic targets.